News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

UK Biotechs Struggle To Cope With Brexit



11/21/2016 7:31:47 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
UK-based biotech companies and their investors are slowly coming to terms with the likely exit or “Brexit” of the United Kingdom from the European Union. Speculation about what Brexit means for biotech has been circulating since the stunning referendum result from June, but the full consequences are still only beginning to sink in. Based on recent conversations with a number of UK venture investors and biotech company CEOs, it seems that there is a growing sense of alarm. In sharp contrast to the early euphoria seen in the market for US biotech company shares over the election of Donald Trump, the UK sector is preparing itself for a painful period of retrenchment.

Read at Forbes


comments powered by Disqus
Forbes
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES